Summertime stings?which actually peak in incidence late in the season?can result in either a mild local reaction and a lesson learned, or a systemic allergic reaction with a devastating outcome. Here are strategies to help you and your patients prevent stings and their potentially devastating outcomes.
Dupilumab (Dupixent) becomes first FDA-approved drug for adolescent CRSwNP
September 13th 2024The landmark indication is supported by a couple of pivotal trials assessing dupilumab for patients with chronic rhinosinusitis with nasal polyps, as well as a pediatric severe asthma trial assessing the biologic.